Has Ajanta Pharma USA Inc had other FDA enforcement actions?

Yes. Argus HQ has recorded 4 total FDA actions tied to Ajanta Pharma USA Inc: 0 warning letters, 4 recalls, 0 approval records, and 0 Form 483 inspection citations.

What kind of FDA record is this?

This is an Argus HQ record of a FDA Recall, tagged high severity by Argus HQ. FDA published the underlying record on 2026-07-01; Argus observed and indexed it on 2026-07-09.

Where can I verify this record directly with FDA?

The verbatim FDA source record is the source of truth — Argus HQ links directly to it below. Always confirm against fda.gov before acting.

.hq

fda_recall · drug_recall · high

Ajanta Pharma USA Inc — Class II recall: Fenofibrate Capsules, USP 200 mg, Rx only, 100 Capsules, Manufactured by: Ajanta…

Name: FDA Recall Record — Ajanta Pharma USA Inc
Creator: Argus HQ
Published: 2026-07-01
License: https://argushq.ai/methodology

Event date: 2026-07-01 00:00:00Z
Observed: 2026-07-09 22:51:30Z
Source ID: D-0611-2026
Payload hash: 4e5ac501594e5c7d328137e5…

Summary

CGMP Deviations Status: Ongoing.

Entities

Ajanta Pharma USA Inc

View source record ↗

Frequently asked questions

Has Ajanta Pharma USA Inc had other FDA enforcement actions?: Yes. Argus HQ has recorded 4 total FDA actions tied to Ajanta Pharma USA Inc: 0 warning letters, 4 recalls, 0 approval records, and 0 Form 483 inspection citations.
What kind of FDA record is this?: This is an Argus HQ record of a FDA Recall, tagged high severity by Argus HQ. FDA published the underlying record on 2026-07-01; Argus observed and indexed it on 2026-07-09.
Where can I verify this record directly with FDA?: The verbatim FDA source record is the source of truth — Argus HQ links directly to it below. Always confirm against fda.gov before acting.

Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder

Cite this record

Reusing this data in reporting or research? Here’s a ready-made citation.

APA

Argus HQ Research (2026). Ajanta Pharma USA Inc — Class II recall: Fenofibrate Capsules, USP 200 mg, Rx only, 100 Capsules, Manufactured by: Ajanta…. Digital Empire Holdings LLC. Retrieved from https://argushq.ai/events/fda-recall-ajanta-pharma-usa-inc-d-0611-2026

MLA

"Ajanta Pharma USA Inc — Class II recall: Fenofibrate Capsules, USP 200 mg, Rx only, 100 Capsules, Manufactured by: Ajanta…." Argus HQ Research, Digital Empire Holdings LLC, 2026, argushq.ai/events/fda-recall-ajanta-pharma-usa-inc-d-0611-2026.

Chicago

Argus HQ Research. "Ajanta Pharma USA Inc — Class II recall: Fenofibrate Capsules, USP 200 mg, Rx only, 100 Capsules, Manufactured by: Ajanta…." Digital Empire Holdings LLC. Accessed October 13, 2026. https://argushq.ai/events/fda-recall-ajanta-pharma-usa-inc-d-0611-2026.

BibTeX

@misc{argushq_argushq_ai_events_fda_recall_ajanta_pharma_usa_inc_d_0611_2026_2026,
  title = {Ajanta Pharma USA Inc — Class II recall: Fenofibrate Capsules, USP 200 mg, Rx only, 100 Capsules, Manufactured by: Ajanta…},
  author = {{Argus HQ Research}},
  year = {2026},
  publisher = {Digital Empire Holdings LLC},
  url = {https://argushq.ai/events/fda-recall-ajanta-pharma-usa-inc-d-0611-2026},
  note = {Accessed: October 13, 2026}
}

Informational only. Not legal, financial, or medical advice.